Sex-specific cardiac and vascular responses to hypertension in Chinese populations without overt cardiovascular diseases

References

• Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602.
   PubMed Web of Science ®Google Scholar
• Gladden JD, Chaanine AH, Redfield MM. Heart failure with preserved ejection fraction. Annu Rev Med. 2018;69:65–79.
   PubMed Web of Science ®Google Scholar
• Solomon SD, McMurray JJV, Anand IS, et al. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. 2019;381(17):1609–1620.
   PubMed Web of Science ®Google Scholar
• Pitt B, Pfeffer MA, Assmann SF, et al. Spironolactone for heart failure with preserved ejection fraction. N Engl J Med. 2014;370(15):1383–1392.
   PubMed Web of Science ®Google Scholar
• Lam CSP, Voors AA, de Boer RA, et al. Heart failure with preserved ejection fraction: from mechanisms to therapies. Eur Heart J. 2018;39(30):2780–2792.
   PubMed Web of Science ®Google Scholar
• Lau ES, Cunningham T, Hardin KM, et al. Sex differences in cardiometabolic traits and determinants of exercise capacity in heart failure with preserved ejection fraction. JAMA Cardiol. 2020:1;5(1):30-37.
   Web of Science ®Google Scholar
• Stolfo D, Uijl A, Vedin O, et al. Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications. JACC Heart Fail. 2019;7(6):505–515.
   PubMed Web of Science ®Google Scholar
• Beale AL, Nanayakkara S, Segan L, et al. Sex differences in heart failure with preserved ejection fraction pathophysiology: a detailed invasive hemodynamic and echocardiographic analysis. JACC Heart Fail. 2019;7(3):239–249.
   PubMed Web of Science ®Google Scholar
• Beale AL, Meyer P, Marwick TH, et al. Sex differences in cardiovascular pathophysiology: why women are overrepresented in heart failure with preserved ejection fraction. Circulation. 2018;138(2):198–205.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Borlaug BA, et al. Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation. 2005;112(15):2254–2262.
   PubMed Web of Science ®Google Scholar
• Okura H, Takada Y, Yamabe A, et al. Age- and gender-specific changes in the left ventricular relaxation: a doppler echocardiographic study in healthy individuals. Circ Cardiovasc Imaging. 2009;2(1):41–46.
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Roger VL, Weston SA, et al. Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail. 2012;5(6):720–726.
   PubMed Web of Science ®Google Scholar
• Piro M, Della Bona R, Abbate A, et al. Sex-related differences in myocardial remodeling. J Am Coll Cardiol. 2010;55(11):1057–1065.
   PubMed Web of Science ®Google Scholar
• Lieb W, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study. Circulation. 2009;119(24):3085–3092.
   PubMed Web of Science ®Google Scholar
• Beale AL, Nanayakkara S, Kaye DM. Impact of sex on ventricular-vascular stiffness and long-term outcomes in heart failure with preserved ejection fraction: TOPCAT trial substudy. J Am Heart Assoc. 2019;8(13):e012190.
   PubMed Web of Science ®Google Scholar
• Gori M, Lam CS, Gupta DK, et al. Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Eur J Heart Fail. 2014;16(5):535–542.
   PubMed Web of Science ®Google Scholar
• Kuch B, Muscholl M, Luchner A, et al. Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens. 1998;12(10):685–691.
   PubMed Web of Science ®Google Scholar
• Cheng S, Fernandes VR, Bluemke DA, et al. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2009;2(3):191–198.
   PubMed Web of Science ®Google Scholar
• Fernandes-Silva MM, Shah AM, Hegde S, et al. Race-related differences in left ventricular structural and functional remodeling in response to increased afterload: the ARIC study. JACC Heart Fail. 2017;5(3):157–165.
   PubMed Web of Science ®Google Scholar
• Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE million persons project). Lancet. 2017;390(10112):2549–2558.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Cardiology of Chinese Medical Association. Chinese guidelines for the prevention of cardiovascular diseases(2017). Zhonghua Xin Xue Guan Bing Za Zhi. 2018;46(1):10–25.
   PubMedGoogle Scholar
• Joint Committee for Guideline Revision. Chinese guidelines for prevention and treatment of hypertension-a report of the revision committee of chinese guidelines for prevention and treatment of hypertension. JGC. 2019;16(3):182–241.
   Google Scholar
• Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–254.
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157–163.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233–270.
   PubMed Web of Science ®Google Scholar
• Tromp J, Teng TH, Tay WT, et al. Heart failure with preserved ejection fraction in Asia. Eur J Heart Fail. 2019;21(1):23–36.
   PubMed Web of Science ®Google Scholar
• Tadic M, Cuspidi C. Hypertension, diastolic stress test, and HFpEF: does new scoring system change something? J Clin Hypertens (Greenwich, CT). 2019;21(12):1905–1907.
   PubMed Web of Science ®Google Scholar
• Zhang H, Hu L, Wei X. Prognostic value of left ventricular hypertrophy in hypertensive patients: a meta-analysis of electrocardiographic studies. J Clin Hypertens (Greenwich, CT). 2020;22(2):254–260.
   PubMed Web of Science ®Google Scholar
• Cai A, Mo Y, Zhang Y, et al. Relationship of pulse pressure index and carotid intima-media thickness in hypertensive adults. Clin Exp Hypertens. 2015;37(4):267–270.
   PubMed Web of Science ®Google Scholar
• Lattanzi S, Brigo F, Silvestrini M. Hypertension and arterial stiffness. J Clin Hypertens (Greenwich, CT). 2019;21(10):1481–1483.
   PubMed Web of Science ®Google Scholar
• Kühl JT, Nielsen JB, Stisen ZR, et al. Left ventricular hypertrophy identified by cardiac computed tomography and ECG in hypertensive individuals: a population-based study. J Hypertens. 2019;37(4):739–746.
   PubMed Web of Science ®Google Scholar
• Johnson K, Oparil S, Davis BR, et al. Prevention of heart failure in hypertension-disentangling the role of evolving left ventricular hypertrophy and blood pressure lowering: the ALLHAT study. J Am Heart Assoc. 2019;8(8):e011961.
   PubMed Web of Science ®Google Scholar
• Soliman EZ, Ambrosius WT, Cushman WC, et al. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with hypertension: SPRINT (Systolic Blood Pressure Intervention Trial). Circulation. 2017;136(5):440–450.
   PubMed Web of Science ®Google Scholar
• Sorimachi H, Kurosawa K, Yoshida K, et al. Sex differences in left ventricular afterload and diastolic function are independent from the aortic size. PloS One. 2019;14(4):e0214907.
   PubMed Web of Science ®Google Scholar
• Park S, Ha JW, Shim CY, et al. Gender-related difference in arterial elastance during exercise in patients with hypertension. Hypertens. 2008;51(4):1163–1169.
   PubMed Web of Science ®Google Scholar
• Fischer M, Baessler A, Schunkert H. Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res. 2002;53(3):672–677.
   PubMed Web of Science ®Google Scholar
• Lam CS, Cheng S, Choong K, et al. Influence of sex and hormone status on circulating natriuretic peptides. J Am Coll Cardiol. 2011;58(6):618–626.
   PubMed Web of Science ®Google Scholar
• Volpe M, Rubattu S, Burnett J Jr. Natriuretic peptides in cardiovascular diseases: current use and perspectives. Eur Heart J. 2014;35(7):419–425.
   PubMed Web of Science ®Google Scholar
• Kerkelä R, Ulvila J, Magga J. Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events. J Am Heart Assoc. 2015;4(10):e002423.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Celis H, Thijs L, et al. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies. Hypertens. 2009;54(5):1084–1091.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Janardhanan R, Verma A, et al. Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. Lancet. 2007;369(9579):2079–2087.
   PubMed Web of Science ®Google Scholar
• Poppe KK, Doughty RN, Gardin JM. Ethnic-specific normative reference values for echocardiographic LA and LV size, LV mass, and systolic function: the EchoNoRMAL study. JACC Cardiovasc Imaging. 2015;8(6):656–665.
   PubMed Web of Science ®Google Scholar